# Viking Therapeutics, Inc.: Form DEF 14A, filed May 1, 2023

- Company: [Viking Therapeutics, Inc.](/companies/vktx.md) (CIK 1607678)
- Form: DEF 14A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 16:01 ET
- Period: not reported
- Accession: 0000950170-23-016221
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1607678/000095017023016221/vktx-20230501.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1607678/000095017023016221/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1607678/000095017023016221/vktx-20230501.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-016221. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.